Skip to main content

Advertisement

SpringerLink
Log in

Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective and design

The aim of this study was to assess the value of procalcitonin (PCT), C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-a), interleukin (IL)-1b, IL-8, and soluble TNF receptor II (sTNFRII) in early and rapid diagnosis of infection in neutropenic children with acute lymphoblastic leukemia (ALL) and to distinguish bacterial from viral infections.

Patients

The study included five groups (A, B, C, D, and E) of children with ALL undergoing intensive chemotherapy. Groups A and B consisted of neutropenic children with bacterial and viral infection, respectively. Groups C and D consisted of nonneutropenic children with bacterial and viral infection, respectively. Group E consisted of children without neutropenia and without fever.

Methods

In all groups, blood samples were collected upon admission and then for 7 days on a daily basis. Levels of CRP, PCT, TNF-a, IL-1b, IL-8, and sTNFRII were determined in all blood samples.

Results

We found a highly significant difference in PCT levels between bacterial and nonbacterial episodes. Sensitivity and specificity of PCT were 94 and 96.5%, respectively.

Conclusions

Serial measurement of PCT levels on a daily basis seems to be helpful for early prediction of severe bacterial infections, monitoring febrile episodes regarding response to antibiotic therapy, and early detection of complications in the infectious process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Finberg RW, Talcott JA. Fever and neutropenia-how to use a new treatment strategy. N Engl J Med. 1999;341(5):362–8.

    Article  PubMed  CAS  Google Scholar 

  2. Crokaert F. Febrile neutropenia in children. Int J Antimicrob Agent. 2000;16:173–7.

    Article  CAS  Google Scholar 

  3. Schimpff SC. Infections in the cancer patients-diagnosis, prevention and treatment. In: Mandell GL, Douglas RG, Bennet JE, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone; 1995. p. 2666.

    Google Scholar 

  4. Laws HJ, Schneider DT, Janssen G, Wessalowski R, Dilloo D, Meisel R, et al. Trends in infections in children with malignant disease in 2000: comparison of data of 1980/81. Pediatr Hematol Oncol. 2000;24(5):343–54.

    Article  Google Scholar 

  5. Von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Macrobiol Infect Dis. 2004;23:539–44.

    Google Scholar 

  6. Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D. Adenosine deaminase activity and isozyme levels in serum and peripheral blood lymphocytes in childhood acute lymphoblastic leukemia. Mol Immunol. 1998;35(11–12):754–9.

    Article  Google Scholar 

  7. Petrola V, Toikka P, Irjala K, Mertsola J, Ruuskanen O. Discrepancy between total white blood cell count and serum C-reactive protein levels in febrile children. Scand J Infect Dis. 2007;39(6):560–5.

    Article  CAS  Google Scholar 

  8. Kalio R, Bloigu A, Surcel HM, Syrjiada H. C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas. Support Care Cancer. 2001;9:124–9.

    Article  Google Scholar 

  9. Hartel C, Deutser M, Lehrnbecher T, Schultz C. Current approaches for risk stratification of infectious complications in pediatric oncology. Pediatr Blood Cancer. 2007;49(6):767–73.

    Article  PubMed  Google Scholar 

  10. Sheu JN, Chen MC, Lue KH, Sl Cheng, Lee IC, Chen SM, et al. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine. 2006;36(5–6):276–82.

    Article  PubMed  CAS  Google Scholar 

  11. Shereen Mohamed EM, Manar Mohamed M, Manar Mohamed I, Lobna M, Hadir A. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies. J Pediatr Hematol Oncol. 2007;29(3):131–6.

    Article  Google Scholar 

  12. Lehrnbecher T, Venzon D, de Haas M, Chanock SJ, Kuel J. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414–9.

    Article  PubMed  CAS  Google Scholar 

  13. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med. 2000;28:458–61.

    Article  PubMed  CAS  Google Scholar 

  14. Hoffmann G, Schobersberger W. Procalcitonin as a marker. Acta Anaesthesiol Scand. 2003;47(2):237–43.

    Article  PubMed  CAS  Google Scholar 

  15. Gendel D, Bohuon C. Procalcitonin a marker of bacterial infection. Infection. 1997;25:133–8.

    Article  Google Scholar 

  16. Whang KT, Steinwald PM, White JC. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab. 1998;83:3296–301.

    Article  PubMed  CAS  Google Scholar 

  17. Emporiadou M, Hatzistilianou M, Haidopoulou K, Aggouridaki C, Reklity A, Magnisali C, et al. Procalcitonin and inflammatory cytokines in children with asthma. Eur J Inflamm. 2005;3(2):75–81.

    CAS  Google Scholar 

  18. Bernard L, Ferriere F, Casassus P, Malas E, Leveque S, Guillevin L. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis. 1998;27:914–7.

    Article  PubMed  CAS  Google Scholar 

  19. Hatzistilianou M, Hitoglou S, Gougoustamou D, Rekliti A, Tzouvelekis G, Nanas C, et al. Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children. Int J Immunopathol Pharmacol. 2002;15(2):119–23.

    PubMed  CAS  Google Scholar 

  20. The Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis. 1990;161:397–404.

    Google Scholar 

  21. Alexander SW, Pizzo PA. Current considerations in the management of fever and neutropenia. In: Remington JS, Swartz MN, editors. Current clinical topics in infectious diseases. Oxford: Blackwell; 1999. p. 160–80.

    Google Scholar 

  22. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551–5.

    Article  PubMed  CAS  Google Scholar 

  23. Penel N, Fournier C, Clisant S, N’Guyen M. Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support Care Cancer. 2004;12:593–7.

    Article  PubMed  Google Scholar 

  24. Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis. 1999;18:283–8.

    Article  PubMed  CAS  Google Scholar 

  25. Schuttrump S, Binder L, Hagemann T, Berkovie D, Trumper L, Binder C. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol. 2003;82:98–101.

    Google Scholar 

  26. Hitoglou S, Hatzistilianou M, Gougoustamou D, Rekliti A, Agguridaki Ch, Athanassiadou F, et al. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukemia. Clin Exp Med. 2005;5:60–5.

    Article  CAS  Google Scholar 

  27. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay M, Huber P, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600–5.

    Article  PubMed  CAS  Google Scholar 

  28. Hatzistilianou M, Rekleity A, Athanassiadou F, Delutils MA, Conti P, Catriu D. Serial procalcitonin responses in infection of children with secondary immunodeficiency. Clin Invest Med. 2007;30(2):75–85.

    Google Scholar 

  29. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351(1–2):17–21.

    Article  PubMed  CAS  Google Scholar 

  30. Chesney J, Metz C, Stavitsky AB, Bacher M, Bacher R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998;160:419–25.

    PubMed  CAS  Google Scholar 

  31. Harbarth S, Holechova K, Froidevaux C, Pittet D, Ricou B, Grau G, et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically III patients admitted with suspected sepsis. J Resp Crit Care Med. 2001;164(3):396–402.

    CAS  Google Scholar 

  32. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble necrosis factor receptor II. Br J Haematol. 2000;111:1093–102.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Paediatrics, Aristotle University of Thessaloniki, Agiou Ioannou 23, Kalamaria, 551 32, Thessaloniki, Greece

    Maria Hatzistilianou, Aleka Rekliti, Fanni Athanassiadou & Dorothea Catriu

Authors
  1. Maria Hatzistilianou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aleka Rekliti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fanni Athanassiadou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dorothea Catriu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Hatzistilianou.

Additional information

Responsible Editor: K. Visvanathan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatzistilianou, M., Rekliti, A., Athanassiadou, F. et al. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm. Res. 59, 339–347 (2010). https://doi.org/10.1007/s00011-009-0100-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-009-0100-0

Keywords

Search

Navigation